Statistics
Publications
14
Citations
1.4K
H-Index
13
Active since
2013
Yingyun Wang is an author at Novartis (Switzerland) specializing in molecular oncology, pharmacology, and medicine.
Publications per year
2013–2025
14
14
Concurrent inhibition of oncogenic and wild-type RAS-GTP for cancer therapy
Matthew Holderfield, Bianca J. Lee, Jingjing Jiang et al. · Nature · 2024 · 318 citations · Full text
Medicine, Oncology, Pharmacology +16
Tumour-selective activity of RAS-GTP inhibition in pancreatic cancer
Urszula N. Wasko, Jingjing Jiang, Tanner C. Dalton et al. · Nature · 2024 · 175 citations · Full text
Medicine, Oncology, Pharmacology +17
Jing Lü, Tatiana Zavorotinskaya, Yumin Dai et al. · Blood · 2013 · 161 citations · Full text
Medicine, Cell Biology, Oncology +8
Pan-PIM Kinase Inhibition Provides a Novel Therapy for Treating Hematologic Cancers
Pablo D. García, John L. Langowski, Yingyun Wang et al. · Clinical Cancer Research · 2014 · 111 citations · Full text
Medicine, Oncology, Pharmacology +17
1–5 of 14